Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

UPSHER SMITH LABS

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 53
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

PROPEL PHARMA

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 45
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 56
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

AUCTA

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 48
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

GRANULES

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 52
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 53
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

MSN

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 44
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

PRINSTON INC

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 54
  • 0 comments

FDA approve BUSULFAN

Comment Full text

UNICHEM

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 46
  • 0 comments

FDA approve CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Comment Full text

ZHEJIANG POLY PHARM

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 58
  • 0 comments

FDA approve AMIODARONE HYDROCHLORIDE

Comment Full text
  • Previous
  • 356
  • 357
  • 358
  • 359
  • 360
  • Next

Search

News categories

  • Technical Exchange News(14653)
  • Event(6229)
  • SEC News(390624)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237966)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin